Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235985 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Chlorhexidine Gluconate Concentration on Skin of Human Subjects Following Multiple Application Times
A Phase 4 study of General Skin Cleansing, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT04235985 is a Phase 4 study of General Skin Cleansing that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04235985, a Phase 4 study of General Skin Cleansing, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the amount of chlorhexidine gluconate (CHG) present on treated skin of human volunteers following different application times with a test material bathing system. The amount of recovered CHG that resides on the skin following each of the evaluated application times will be evaluated via high performance liquid chromatography with ultraviolet detection (HPLC-UV) and correlated with the MIC values determined separately.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Chlorhexidine Gluconate with HUBS
Study Locations (1)
Montana
- Bioscience Laboratories, Inc - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2020-04-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04235985
The ClinicalTrials.gov registry entry for NCT04235985 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with General Skin Cleansing appearing as the primary indexed condition, and to 1 intervention - of which Chlorhexidine Gluconate with HUBS is the first listed.
NCT04235985 reports 1 study location spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT04235985 about?
NCT04235985 is a clinical study titled "Evaluation of Chlorhexidine Gluconate Concentration on Skin of Human Subjects Following Multiple Application Times". This study will evaluate the amount of chlorhexidine gluconate (CHG) present on treated skin of human volunteers following different application times with a test material bathing system. The amount of recovered CHG that resides on the skin following each of the evaluated application times will be e...
What is the current status of trial NCT04235985?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2020-01-23. Estimated completion is 2020-04-02.
What conditions does trial NCT04235985 study?
This clinical trial studies the following conditions: General Skin Cleansing.
What interventions are being tested in trial NCT04235985?
The interventions under investigation include: Chlorhexidine Gluconate with HUBS (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04235985?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04235985 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.